Correlation Between Enfusion and Agilysys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enfusion and Agilysys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Agilysys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Agilysys, you can compare the effects of market volatilities on Enfusion and Agilysys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Agilysys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Agilysys.

Diversification Opportunities for Enfusion and Agilysys

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Enfusion and Agilysys is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Agilysys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilysys and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Agilysys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilysys has no effect on the direction of Enfusion i.e., Enfusion and Agilysys go up and down completely randomly.

Pair Corralation between Enfusion and Agilysys

Given the investment horizon of 90 days Enfusion is expected to generate 0.44 times more return on investment than Agilysys. However, Enfusion is 2.26 times less risky than Agilysys. It trades about 0.07 of its potential returns per unit of risk. Agilysys is currently generating about -0.25 per unit of risk. If you would invest  1,047  in Enfusion on December 30, 2024 and sell it today you would earn a total of  63.00  from holding Enfusion or generate 6.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Enfusion  vs.  Agilysys

 Performance 
       Timeline  
Enfusion 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Agilysys 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Agilysys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Enfusion and Agilysys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enfusion and Agilysys

The main advantage of trading using opposite Enfusion and Agilysys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Agilysys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilysys will offset losses from the drop in Agilysys' long position.
The idea behind Enfusion and Agilysys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk